Imbalances of Pro-inflammatory cytokines in myocardial infarction patients

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Diabetology

Background:

• Myocardial Infarction (MI) is a critical cardiovascular event.
• Inflammatory markers like Interleukin-1 beta (IL-1β) and C-reactive protein (CRP) are implicated in cardiovascular disease.
• Diabetes Mellitus Type II (DMT-II) is a significant risk factor for cardiovascular complications.

Purpose of the Study:

• To assess Interleukin-1 beta (IL-1β) and C-reactive protein (CRP) levels in diabetic and non-diabetic Myocardial Infarction (MI) patients.
• To evaluate the impact of angioplasty on these inflammatory markers.
• To compare metabolic profiles and clinical parameters between MI patients with and without DMT-II.

Main Methods:

• A study involving 200 MI patients (aged 40-60) divided into two groups: with and without DMT-II.
• Biochemical analyses included serum triglycerides, cholesterol, LDL, HDL, Fasting Blood Sugar (FBS), Insulin, HbA1C, IL-1β, and CRP.
• Measurements were taken prior to and post angioplasty using enzymatic kits, RIA, and ELISA.

Main Results:

• IL-1β and CRP levels were significantly higher prior to angioplasty compared to post-angioplasty levels in both groups (P<0.001).
• MI patients without DMT-II showed significantly higher FBS and Insulin, and lower HDL and HbA1C compared to those with DMT-II (P<0.001).
• MI patients with DMT-II had significantly higher Body Mass Index (BMI) and Systolic Blood Pressure (SBP) (P<0.001).

Conclusions:

• Elevated IL-1β and CRP levels before angioplasty highlight their crucial role in ischemia and MI development.
• DMT-II influences metabolic profiles and clinical characteristics in MI patients.
• Angioplasty may lead to a reduction in key inflammatory markers associated with MI.